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Abstract: Background: Current evidence supports the central role of a subclinical, low-grade
inflammation in a number of chronic illnesses and mental disorders; however, studies on sleep quality
are scarce. The aim of this study was to test the association between the inflammatory potential of the
diet and sleep quality in a cohort of Italian adults. Methods: A cross-sectional analysis of baseline
data of the Mediterranean healthy Eating, Aging, and Lifestyle (MEAL) study was conducted on
1936 individuals recruited in the urban area of Catania during 2014–2015 through random sampling.
A food frequency questionnaire and other validated instruments were used to calculate the dietary
inflammatory index (DII®) and assess sleep quality (Pittsburg sleep quality index). Multivariable
logistic regression analyses were performed to determine the association between exposure and
outcome. Results: Individuals in the highest quartile of the DII were less likely to have adequate
sleep quality (odds ratio (OR) = 0.49, 95% CI: 0.31, 0.78). Among individual domains of sleep quality,
an association with the highest exposure category was found only for sleep latency (OR = 0.60, 95%
CI: 0.39, 0.93). Conclusions: The inflammatory potential of the diet appears to be associated with
sleep quality in adults. Interventions to improve diet quality might consider including a dietary
component that aims to lower chronic systemic inflammation to prevent cognitive decline and
improve sleep quality.
Keywords: sleep quality; cognitive decline; dementia; mental health; cohort; Italy; dietary
inflammatory index; diet; inflammation; dietary patterns
1. Introduction
Inflammation represents an important physiological defense mechanism that protects the human
body from external insults. As long as the inflammatory response is properly regulated—in response
to real insults and counteracted by negative feedback mechanisms—it remains an essential mechanism
for the maintenance of body homeostasis [1]. However, current evidence supports the central role
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of a subclinical, low-grade systemic inflammation in a number of chronic illnesses [2]. Elevated
circulating levels of markers of inflammation, including C-reactive protein (CRP), tumor necrosis factor
(TNF)-alpha, and interleukin (IL)-1 and IL-6, may lead to inflammation of the central nervous system,
which has a role in the progression of chronic neurodegenerative disease [3]. Consequently, there is a
growing body of research investigating whether such markers prompted by inflammation might also
contribute to their pathogenesis [4]. Pathological alterations in sleeping behaviors and inflammatory
disease states have common origins that involve an increased number of inflammatory cytokines [5].
Metabolic and immunological consequences of sleep deprivation seem to lead to antioxidant imbalance,
including perturbations in catalase and glutathione peroxidase levels, as well as indexes of glutathione
recycling activities, which are decreased after sleep deprivation, while recovery sleep normalizes
antioxidant content and enhances enzymatic antioxidant activities [6]. A similar relation to circulating
levels of inflammatory biomarkers has also been observed with affective and cognitive disorders [7].
Several biomarkers of inflammation and antioxidants, such as CRP, γ-glutamyl transferase (GGT),
carotenoids, uric acid, vitamin C, and vitamin D, have been associated with sleep quality parameters
and duration [8,9].
Inflammation has been hypothesized to be a link that mediates diet and chronic diseases [10].
There is consistent evidence suggesting that "Western-like" dietary patterns, characterized by high
intake of processed, refined foods, tend to be positively associated with biomarkers of inflammation,
predominantly CRP, while vegetable- and fruit-based or "healthy" patterns tend to be inversely
associated [11]. Evidence on the relation between diet and low-grade inflammation has been further
strengthened following comprehensive analyses of intervention trials showing that a healthy dietary
pattern was associated with significant reductions in CRP [12]. Among the various investigated dietary
patterns, the Mediterranean diet has been associated with lower concentrations of inflammatory
biomarkers (including CRP and IL-6) [13].
The Dietary Inflammatory Index (DII®) is a literature-derived score that has been developed to
evaluate the inflammatory potential of the diet and link diet to inflammation. It takes into account six
inflammatory markers (i.e., CRP, IL-1beta, IL-4, IL-6, IL-10, and TNF-alpha) [14]. The DII has proven to
be of value for its association with health status in the general population [15–17]. Along with 18 other
construct validations that use circulating inflammatory biomarkers, it has been tested for validity in
a population living in the Mediterranean area [18]. Recent studies showed a potential association
between adherence to a Mediterranean diet and parameters of sleep quality [19–21]. However, no study
focusing on the relationship between the DII and sleep has been published (though one study in
Korea [22] did consider sleep when assessing the relationship between the DII and cognitive decline
in older adults). Thus, the aim of this study was to test the association between DII scores and sleep
quality in a cohort of Italian adults.
2. Materials and Methods
2.1. Study Population
The Mediterranean healthy Eating, Aging, and Lifestyles (MEAL) study is an observational
study designed to explore the relation between nutritional and lifestyle behaviors that characterizes
individuals living in the Mediterranean area. The results of a cross-sectional analysis of baseline
data are presented in this manuscript. The details of the study protocol, with the rationale, design,
and methods, have been described elsewhere [23]. Briefly, the cohort consisted of a random sample of
2044 men and women (age 18+ years) recruited in the urban area of Catania, one of the largest cities of
the eastern cost of Sicily, southern Italy, during 2014–2015. All study procedures were carried out in
accordance with the Declaration of Helsinki (1989) of the World Medical Association. Participants
provided written informed consent, and the study protocol was approved by the ethics committee of
the referent health authority.
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2.2. Data Collection
Data regarding demographic (i.e., age, sex, educational level, and occupational level) and lifestyle
characteristics (i.e., physical activity, smoking habits, and drinking habits) were collected. Educational
level was categorized as: (i) low (primary/secondary), (ii) medium (high school), and (iii) high
(university). Occupational level was classified as: (i) unemployed, (ii) low (unskilled workers),
(iii) medium (partially skilled workers), and (iv) high (skilled workers). Physical activity level was
assessed using the International Physical Activity Questionnaires (IPAQ) [24], which comprised a set
of questionnaires (five domains) on time spent being physically active in the last 7 days that allow us
to categorize physical activity as: (i) low, (ii) moderate, and (iii) high. Smoking status was classified
as: (i) non-smoker, (ii) ex-smoker, and (iii) current smoker. Alcohol consumption was categorized as
(i) none, (ii) moderate drinker (0.1–12 g/day), and (iii) regular drinker (>12 g/day). Anthropometric
measurements were performed according to standardized methods [25]. Height of the participant,
without shoes with the back square against the wall tape, eyes looking straight ahead, with a right-angle
triangle resting on the scalp and against the wall, was measured by a health professional to the nearest
0.5 cm. Body mass index (BMI) was calculated from measured height and weight, and patients were
categorized as under/normal weight (BMI <25 kg/m2), overweight (BMI 25–29.9 kg/m2), and obese
(BMI ≥30 kg/m2) [26].
2.3. Dietary Assessment
Dietary data were collected using a validated food frequency questionnaire (FFQ) consisting
of 100 food and drink items representative of the diet during the last 6 months [27,28]. Participants
were asked how often, on average, they had consumed foods and drinks included in the FFQ, with
nine responses ranging from "never" to "4–5 times per day". Intake of food items characterized by
seasonality referred to consumption during the period in which the food was available and then
adjusted by its proportional intake over one year. After excluding data on 107 participants with
unreliable dietary intakes (<1000 or >6000 kcal/d), data from a total of 1936 individuals were included
in the analyses for the present study. Following the identification of the food intake, the energy content
as well as the micro-nutrient intake was obtained using standard food composition tables of the Italian
Research Center for Foods and Nutrition [29]. The process of the estimation of polyphenol intakes
has been previously described in detail [30]. Briefly, data on the polyphenol content in foods were
retrieved from the Phenol-Explorer database (www.phenol-explorer.eu) [31], using the most recent
version of the database containing data on the effects of cooking and food processing on polyphenol
contents in order to apply polyphenol-specific retention factors [32]. Micro-nutrient, macro-nutrient,
and polyphenol intake were adjusted for total energy intake (kcal/day) using the residual method [33].
Finally, a Mediterranean diet adherence score was calculated based on a previously published
methodology [34] using literature-derived weighted median servings of foods characterizing this
dietary pattern (including olive oil, fruit, vegetables, cereals, legumes, fish, and moderate alcohol intake
indicating higher adherence and meat and meat-based products, dairy products, and no/excessive
alcohol consumption indicating lower adherence; the final score comprised nine food categories with a
score ranging from 0 points (lowest adherence) to 18 points (highest adherence) [35].
2.4. DII Score
A complete description of the process of developing the DII has been published elsewhere [14,36].
Briefly, the dietary data of the sample were first linked to the world database that provided a robust
estimate of a mean and SD for each parameter [14]. This was achieved by subtracting the “standard
global mean” from the intake reported via the FFQ and dividing this value by the standard deviation
(SD) to obtain “z” scores. To minimize the effect of “right skewing”, these “z” scores were then converted
to a centered proportion. The centered proportion for each food parameter for each individual was
then multiplied by the respective food parameter effect score (inflammatory potential for each food
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parameter), which was derived from a literature review, to obtain a food-parameter-specific DII score for
an individual. All of the food-parameter–specific DII scores were then summed to create the overall DII
score for each participant in the study [14]. Finally, energy-adjusted DII (E-DII) scores were calculated
using the density method, wherein all food parameters were converted to per 1000 kcal of nutrients
and the same procedure was used to relate individual exposure data to the global energy-adjusted
database. The DII was based on a total of 33 food parameters (energy, carbohydrate, protein, total
fat, alcohol, fiber, cholesterol, saturated fatty acid, monounsaturated fatty acid, polyunsaturated fatty
acid, omega 3, omega 6, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, folic
acid, iron, magnesium, zinc, selenium, anthocyanidins, flavan3ols, flavones, flavonols, flavonones,
isoflavones, garlic, tea, and onion) that were available for the MEAL cohort. The E-DII score was based
on 32 food parameters (all of the previous, except for energy).
2.5. Sleep Quality
The Pittsburgh sleep quality index (PSQI) [37] was used to assess participants’ sleep quality and
disturbances in the past six months. It consists of 19 items that are rated on a four-point scale (0–3) and
grouped into seven components (sleep quality, sleep latency, sleep duration, habitual sleep efficiency,
sleep disturbance, use of sleeping medications, and daytime dysfunction). The item scores in each
component were summed and converted to component scores ranging from 0 (better) to 3 (worse)
based on guidelines. Total PSQI score was calculated as the summation of seven component scores
ranging from 0 to 21, where a higher score indicates worse sleep. A score of <5 on total global PSQI
score is indicative of adequate sleep quality.
2.6. Statistical Analysis
Categorical variables are presented as frequencies of occurrence and percentages, and continuous
variables are presented as the mean and standard deviation (SD); differences between groups were
tested using a Chi-squared test or a Student’s t-test, respectively. The DII was analyzed both as a
categorical (quartiles) or a continuous (1 SD increment) variable. The relation between the DII and
sleep-related outcomes was tested using a simple univariable (unadjusted) and multivariable logistic
regression analysis adjusted for baseline characteristics (age, sex, marital, educational, and occupational
status, smoking and alcohol drinking habits, and physical activity level) comparing individuals grouped
into quartiles or estimating the association by a 1 SD increment of the DII. Because previous studies
suggested a potential role of the Mediterranean diet in sleep quality [19,20] as well as a previous
analysis in the cohort [21], we also tested whether the association between DII and sleep quality was
independent of adherence to this dietary pattern by performing an additional model that further
adjusted for the Mediterranean diet adherence score. All reported P values were based on two-sided
tests and compared to a significance level of 5%. The SPSS® 17 (SPSS Inc., Chicago, IL, USA) software
was used for all of the statistical analyses.
3. Results
The distribution of background variables by quartiles of DII is shown in Table 1. There were no clear
trends in the distribution of age, sex, weight, or health status across DII quartiles. However, a higher
proportion of individuals in lower occupational status categories were found in the lower quartiles of
DII, while those with medium–high status had significantly higher DII scores. Moreover, there was
a higher proportion of regular alcohol drinkers in the lower quartiles of DII, while none–moderate
drinkers had higher DII scores (Table 1).
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Table 1. Baseline characteristics of the study sample according to Dietary Inflammatory Index
(DII) quartiles.
DII Quartiles
p-Value
Q1 Q2 Q3 Q4
Age groups, n (%) <0.001
<30 95 (19.4) 85 (16.7) 81 (16.1) 89 (20.5)
30–49 184 (37.6) 169 (33.1) 196 (39.0) 154 (35.4)
50–69 160 (32.7) 190 (37.3) 166 (33.1) 109 (25.1)
≥70 50 (10.2) 66 (12.9) 59 (11.8) 83 (19.1)
Men, n (%) 174 (35.4) 235 (46.1) 214 (43.1) 181 (41.4) 0.006
Weight status, n (%) 0.01
BMI <25 240 (52.5) 197 (41.9) 202 (44.2) 212 (51.2)
BMI 25–30 151 (33.0) 179 (38.1) 170 (37.2) 130 (31.4)
BMI >30 66 (14.4) 94 (20.0) 85 (18.6) 72 (17.4)
Smoking status, n (%) 0.93
Current 120 (24.4) 121 (23.7) 112 (22.5) 112 (25.6)
Former 67 (13.6) 78 (15.3) 71 (14.3) 60 (13.7)
Never 305 (62.0) 311 (61.0) 314 (63.2) 265 (60.6)
Educational level, n (%) 0.26
Low 186 (37.8) 189 (37.1) 161 (32.4) 161 (36.8)
Medium 189 (38.4) 190 (37.3) 192 (38.6) 149 (34.1)
High 117 (23.8) 131 (25.7) 144 (29.0) 127 (29.1)
Occupational level, n (%) 0.001
Unemployed 145 (34.8) 98 (22.4) 132 (30.8) 86 (22.9)
Low 70 (16.8) 81 (18.5) 61 (14.3) 54 (14.4)
Medium 94 (22.5) 127 (29.1) 108 (25.2) 111 (29.5)
High 108 (25.9) 131 (30.0) 127 (29.7) 125 (33.2)
Physical activity level, n
(%) 0.15
Low 92 (21.1) 75 (17.0) 86 (19.1) 76 (18.9)
Medium 206 (47.2) 209 (47.5) 223 (49.6) 218 (54.2)
High 138 (31.7) 156 (35.5) 141 (31.3) 108 (26.9)
Alcohol consumption, n
(%) <0.001
None 88 (17.9) 91 (17.8) 107 (21.5) 88 (20.1)
Moderate (0.1–12 g/day) 252 (51.2) 312 (61.2) 332 (66.8) 310 (70.9)
Regular (>12 g/day) 152 (30.9) 107 (21.0) 58 (11.7) 39 (8.9)
Health status, n (%)
Hypertension 220 (44.7) 279 (54.7) 254 (51.1) 223 (51.0) 0.02
Diabetes 34 (6.9) 49 (9.6) 44 (8.9) 19 (4.3) 0.01
Dyslipidemias 101 (20.5) 99 (19.4) 80 (16.1) 76 (17.4) 0.27
Cardiovascular disease 42 (8.7) 34 (7.0) 43 (8.8) 35 (8.1) 0.70
Cancer 24 (4.9) 16 (3.1) 15 (3.0) 23 (5.3) 0.17
The frequency of adequate overall sleep quality and its individual domains across quartiles of DII
are shown in Table 2. A lower proportion of participants with adequate sleep quality was found among
higher quartiles of DII. Among individual domains, a significantly higher rate of sleep disturbance
and low self-rated sleep quality was found among participants with higher DII scores (Table 2).
Table 3 provides a direct comparison of mean DII scores between individuals with
adequate/inadequate sleep quality features. Overall, the results reflected the previous findings,
with average DII scores higher among individuals with inadequate sleep quality, self-rated sleep
quality, and, in addition, long sleep latency and efficiency (Table 3).
The association of overall sleep quality and its individual domains with the DII is shown in Table 4.
Individuals in the highest quartile of DII were less likely to have adequate sleep quality (odds ratio
(OR) = 0.49, 95% CI: 0.31, 0.78); the association remained significant also when considering a 1-SD
increment of the score (OR = 0.73, 95% CI: 0.61, 0.88). Among individual domains of sleep quality, an
association with the highest exposure category was found only for sleep latency (OR = 0.60, 95% CI:
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0.39, 0.93), while the linear association with a 1-SD increment of the score was significant for sleep
duration (OR = 0.79, 95% CI: 0.66, 0.93; Table 4).
Table 2. Overall sleep quality and sleep-related characteristics of the study participants by quartiles of
Dietary Inflammatory Index (DII).
DII Quartiles
Q1 Q2 Q3 Q4 p-Value
Adequate sleep quality, n (%) 357 (72.6) 339 (66.5) 340 (68.4) 278 (63.6) 0.03
Sleep duration, n (%) 0.71
>7 h 296 (60.2) 316 (62.0) 292 (58.8) 260 (59.5)
6–7 h 121 (24.6) 108 (21.2) 106 (21.3) 100 (22.9)
5–6 h 49 (10.0) 58 (11.4) 71 (14.3) 52 (11.9)
<5 h 26 (5.3) 28 (5.5) 28 (5.6) 25 (5.7)
Sleep disturbance, n (%) 0.04
None 70 (14.2) 53 (10.4) 57 (11.5) 36 (8.2)
Low 366 (74.4) 373 (73.1) 368 (74.0) 330 (75.5)
Medium 56 (11.4) 84 (16.5) 72 (14.5) 71 (16.2)
High 0 0 0 0
Sleep latency, n (%) 0.17
Very short 227 (46.1) 240 (47.1) 221 (44.5) 170 (38.9)
Short 157 (31.9) 152 (29.8) 173 (34.8) 147 (33.6)
Medium 83 (16.9) 85 (16.7) 79 (15.9) 86 (19.7)
Long 25 (5.1) 33 (6.5) 24 (4.8) 34 (7.8)
Day dysfunction due to
sleepiness, n (%) 0.30
None 300 (61.0) 273 (53.5) 273 (54.9) 234 (53.5)
Low 163 (33.1) 196 (38.4) 181 (36.4) 159 (36.4)
Medium 27 (5.5) 39 (7.6) 41 (8.2) 42 (9.6)
High 2 (0.4) 2 (0.4) 2 (0.4) 2 (0.5)
Sleep efficiency, n (%) 0.27
High 360 (73.2) 365 (71.6) 342 (68.8) 303 (69.3)
Medium 64 (13.0) 75 (14.7) 82 (16.5) 68 (15.6)
Low 27 (5.5) 32 (6.3) 21 (4.2) 33 (7.6)
Very low 41 (8.3) 38 (7.5) 52 (10.5) 33 (7.6)
Self-rated sleep quality, n (%) <0.05
Very low 16 (3.3) 16 (3.1) 13 (2.6) 21 (4.8)
Low 57 (11.6) 91 (17.8) 70 (14.1) 61 (14.0)
Medium 301 (61.2) 286 (56.1) 307 (61.8) 276 (63.2)
High 118 (24.0) 117 (22.9) 107 (21.5) 79 (18.1)
Need of medication to sleep, n (%) 0.44
Not during the past month 453 (92.1) 453 (88.8) 447 (89.9) 391 (89.5)
Less than once a week 16 (3.3) 23 (4.5) 20 (4.0) 15 (3.4)
Once or twice a week 5 (1.0) 13 (2.5) 16 (3.2) 13 (3.0)
Three or more times a week 18 (3.7) 21 (4.1) 14 (2.8) 18 (4.1)
Table 3. Mean scores (and standard deviation) of Dietary Inflammatory Index (DII) by outcome.
DII, Mean (SD) p-Value
Sleep quality <0.001
Inadequate −0.67 (2.09)
Adequate −1.05 (2.10)
Sleep duration 0.16
Inadequate −0.85 (2.09)
Adequate −0.98 (2.10)
Sleep disturbance 0.006
Inadequate −0.88 (2.11)
Adequate −1.30 (1.96)
Sleep latency 0.01
Inadequate −0.82 (2.10)
Adequate −1.06 (2.10)
Day dysfunction 0.09
Inadequate −0.84 (2.08)
Adequate −1.00 (2.11)
Sleep efficiency 0.01
Inadequate −0.74 (2.06)
Adequate −1.00 (2.11)
Need of medication
to sleep 0.14
Inadequate −0.72 (1.95)
Adequate −0.95 (2.11)
Self-rated sleep
quality 0.006
Inadequate −0.86 (2.12)
Adequate −1.18 (2.00)
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Table 4. Association between overall and individual domains of sleep quality † by quartiles of the DII.
DII, OR (95% CI) 1-SD
IncrementQ1 Q2 Q3 Q4
Adequate sleep quality
Model 1 ‡ 1 0.67 (0.51, 0.88) 0.65 (0.49, 0.86) 0.57 (0.43, 0.75) 0.83 (0.75, 0.92)
Model 2 § 1 0.76 (0.54, 1.07) 0.79 (0.56, 1.11) 0.67 (0.47, 0.95) 0.86 (0.76, 0.97)
Model 3 ¶ 1 0.67 (0.47, 0.96) 0.65 (0.44, 0.96) 0.49 (0.31, 0.78) 0.73 (0.61, 0.88)
Sleep duration
Model 1 ‡ 1 1.02 (0.79, 1.31) 0.84 (0.65, 1.08) 0.89 (0.68, 1.15) 0.93 (0.85, 1.03)
Model 2 § 1 1.19 (0.86, 1.64) 1.00 (0.73, 1.37) 1.00 (0.72, 1.38) 0.95 (0.85, 1.07)
Model 3 ¶ 1 1.04 (0.75, 1.46) 0.77 (0.53, 1.12) 0.67 (0.43, 1.04) 0.79 (0.66, 0.93)
Sleep disturbance
Model 1 ‡ 1 0.66 (0.45, 0.96) 0.73 (0.50, 1.06) 0.52 (0.34, 0.80) 0.81 (0.69, 0.94)
Model 2 § 1 0.73 (0.46, 1.16) 0.76 (0.48, 1.20) 0.56 (0.34, 0.93) 0.82 (0.69, 0.98)
Model 3 ¶ 1 0.73 (0.45, 1.19) 0.79 (0.46, 1.35) 0.62 (0.31, 1.21) 0.84 (0.65, 1.09)
Sleep latency
Model 1 ‡ 1 0.95 (0.74, 1.22) 0.83 (0.65, 1.07) 0.69 (0.53, 0.90) 0.89 (0.81, 0.97)
Model 2 § 1 1.00 (0.73, 1.36) 0.87 (0.64, 1.19) 0.73 (0.53, 1.01) 0.90 (0.80, 1.01)
Model 3 ¶ 1 0.93 (0.67, 1.28) 0.77 (0.54, 1.10) 0.60 (0.39, 0.93) 0.85 (0.72, 1.00)
Day dysfunction
Model 1 ‡ 1 0.70 (0.55, 0.90) 0.73 (0.57, 0.94) 0.70 (0.54, 0.91) 0.92 (0.84, 1.01)
Model 2 § 1 0.67 (0.49, 0.92) 0.75 (0.54, 1.02) 0.66 (0.48, 0.91) 0.90 (0.80, 1.01)
Model 3 ¶ 1 0.67 (0.48, 0.94) 0.76 (0.53, 1.10) 0.68 (0.44, 1.06) 0.94 (0.79, 1.11)
Sleep efficiency
Model 1 ‡ 1 0.85 (0.64, 1.12) 0.68 (0.52, 0.90) 0.74 (0.55, 0.99) 0.88 (0.79, 0.97)
Model 2 § 1 0.91 (0.64, 1.29) 0.79 (0.56, 1.12) 0.87 (0.61, 1.23) 0.91 (0.80, 1.04)
Model 3 ¶ 1 0.88 (0.61, 1.27) 0.75 (0.50, 1.11) 0.78 (0.48, 1.25) 0.85 (0.71, 1.02)
Need of medication to sleep
Model 1 ‡ 1 0.63 (0.41, 0.98) 0.67 (0.43, 1.05) 0.67 (0.43, 1.06) 0.89 (0.76, 1.04)
Model 2 § 1 0.72 (0.42, 1.24) 0.84 (0.48, 1.45) 0.92 (0.52, 1.63) 0.99 (0.81, 1.21)
Model 3 ¶ 1 0.67 (0.38, 1.17) 0.76 (0.40, 1.44) 0.79 (0.37, 1.69) 0.92 (0.69, 1.22)
Self-rated sleep quality
Model 1 ‡ 1 0.92 (0.69, 1.22) 0.78 (0.58, 1.05) 0.65 (0.47, 0.89) 0.85 (0.76, 0.96)
Model 2 § 1 1.10 (0.76, 1.58) 0.99 (0.69, 1.44) 0.75 (0.50, 1.11) 0.90 (0.78, 1.03)
Model 3 ¶ 1 1.18 (0.81, 1.72) 1.15 (0.75, 1.77) 0.97 (0.58, 1.64) 1.01 (0.83, 1.23)
† Higher scores indicate worse quality. ‡ Model 1 is unadjusted for any covariate. § Model 2 is adjusted for age
(continuous), sex (male/female), body mass index (BMI, <25 kg/m2, 25–30 kg/m2, >30 kg/m2), physical activity
(low/medium/high), educational status (low/medium/high), occupational status (unemployed/low/medium/high),
smoking status (current/former/never), alcohol consumption (no/moderate/regular), health status (presence of
hypertension, type-2 diabetes, dyslipidemias, cardiovascular disease, cancer), and total energy intake. ¶ Model 3
adjusted as in Model 2 + adherence to Mediterranean diet.
4. Discussion
In the present study, the relation between DII and sleep quality was investigated in a cohort
of Italian adults. Individuals with higher DII scores were found to be significantly less likely to
have adequate sleep quality. Among the various individual components of the sleep quality score,
the strongest association was found for sleep latency. Interestingly, after adjusting for adherence
to the Mediterranean diet, the association between DII and sleep became even stronger, suggesting
that if both the DII and the Mediterranean diet act through a similar mechanism of action related
to inflammation, the DII is a stronger predictor for the inflammatory potential of the diet. To our
knowledge, this is the first study to focus on the relation between the inflammatory potential of diet
and sleep quality parameters.
Existing studies on the role of nutrition in sleep quality by a mediating effect of inflammatory
biomarkers are scarce. A study conducted on about 1500 community-dwelling middle-aged
men reported that an inverse association between plant-sourced dietary pattern (characterized by
beta-carotene, vitamin A, lutein, and zeaxanthin) and CRP was stronger in participants with severe sleep
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apnoea [38]. In a study exploring the association of sleep with metabolic pathways and metabolites,
researchers have found that several metabolites that have previously been linked to inflammation and
oxidative stress, including erythrulose (advanced glycation end-product) (positive association) and
severalγ-glutamyl pathway metabolites, including 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid
(CMPF, fatty acid, dicarboxylate), isovalerate (valine, leucine, and isoleucine and fatty acid metabolism),
and inflammation associated complement component 3 peptide (HWESASXX) (inverse association)
were associated with sleep parameters (i.e., duration) [39]. Data on about 2000 individuals from the
National Health and Nutrition Examination Survey (NHANES) revealed that both healthy eating and
adequate sleep were the two health behavior pairs associated with lower levels of inflammation [40].
More in-depth studies conducted on the same cohort showed that adequate sleep quality was
associated with optimal inflammation, oxidative stress, and antioxidant level, while selected sleep
quality–cardio–metabolic health relationships were moderately mediated by C-reactive protein (CPR)
and vitamins A and C; additionally, in women only, the indirect effects were moderate-to-large for
CRP, GGT, carotenoids, uric acid, and vitamin C [8]. Specifically, moderate-to-large indirect mediation
by GGT, carotenoids, uric acid, and vitamin D was found for sleep duration to waist circumference
and systolic blood pressure relationships, whereas vitamin C was a moderate mediator of the sleep
duration to diastolic blood pressure relationship [9]. These results suggest that inflammation may
be a key mediating effect between sleep-related disorders and other conditions known to be related
to a subclinical, low-grade inflammatory status. Chronic alteration of sleep quality has been related
to mental health impairment and increased risk of cognitive disorders, including stress, depression,
dementia, and Alzheimer’s disease [41]. Diet has been studied over the last few decades for its potential
role in affecting mental health. A number of comprehensive reviews of the literature have been
performed to investigate the role of diet in affective and cognitive disorders that may be related to sleep
impairment. A meta-analysis showed that a high-quality diet, regardless of type (i.e., healthy/prudent
or Mediterranean) together with a relatively low dietary inflammatory index was associated with a
lower risk of depressive symptoms [42]. Similarly, another meta-analysis investigating a posteriori
derived dietary patterns showed that a diet characterized by a high intakes of fruit, vegetables, whole
grain, fish, olive oil, low-fat dairy, and antioxidants and low intakes of animal-derived foods was
apparently associated with a decreased risk of depression; in contrast, a dietary pattern characterized
by a high consumption of red and/or processed meat, refined grains, sweets, high-fat dairy products,
butter, potatoes, and high-fat gravy, and low intakes of fruits and vegetables was associated with an
increased risk of depression [43]. There also is evidence that a pro-inflammatory diet, as indicated
by a higher DII score, may be associated with an increased risk of having depressive symptoms [44].
Regarding cognitive disorders, a systematic review exploring their relation with various dietary
patterns showed that the Mediterranean diet had the strongest evidence supporting protection against
cognitive decline among older adults. However, studies on the Dietary Approach to Stop Hypertension
(DASH) diet, the Mediterranean-DASH diet, the Intervention for Neurodegenerative Delay (MIND)
diet, the anti-inflammatory diet and the healthy diet recommended by guidelines via the dietary index,
and prudent healthy diets generated via statistical approaches also provided promising results [45].
Moreover, previous studies specifically investigating the inflammatory potential of the diet showed
that pro-inflammatory dietary patterns (also identified by higher DII scores) were associated with
higher concentrations of inflammatory markers and accelerated cognitive decline at older ages [46,47].
The mechanisms through which diet may influence mental health features include effects on
inflammation and oxidative stress, as well as a direct effect through the gut–brain axis. The relation
between the DII and mental health may depend, at least in part, on the underlying potential effect
of specific foods and compounds on influencing inflammatory pathways. In fact, several dietary
factors have been hypothesized to play a role in systemic inflammation [48]. Plant-derived foods
are important sources of antioxidants, including vitamins and polyphenols, which have been shown
to contribute to inflammatory response and may exert neuroprotective effects and reduce oxidative
damage [49]. Healthy fats, such as mono- and certain poly-unsaturated fatty acids, have been shown
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to play a significant role in neuroinflammation leading to a lower risk of affective disorders and could
improve inflammation-associated depressive symptoms [50]. In contrast, food sources of refined
carbohydrates may negatively affect dietary glycemic load and index, which have been associated with
an acute inflammatory response [51]. Similarly, consumption of meat products has been associated with
production of inflammation-provoking antibodies and an increase in pro-inflammatory response [52].
Besides its direct metabolic effects and immunologic responses related to nutritional factors, diet
is known to influence the gut microbiota, which may play a role in chronic and low-grade activation of
the inflammatory system’s spread from peripheral tissue to the brain [53]. In fact, there is a large body
of experimental and clinical studies suggesting a mechanistic link between gut-derived inflammatory
response and neurodegeneration, potentially contributing to the pathogenesis of affective and cognitive
disorders [54]. This inflammatory status could be triggered by changes in the gut microbiota’s
composition and dysbiosis due to dietary habits, i.e., consumption of pro-inflammatory diets, high in
fat and sugar, in contrast to high fiber and whole grains, which would lead to an anti-inflammatory
response [55,56]. The mechanisms involved in the process have yet to be fully elucidated, but they
may include the modulation of plasma levels of lipopolysaccharide, and the inflammasome, type
I interferon, and NF-KB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling
pathways [57].
The present study has some limitations that should be kept in mind when considering its results.
First, the cross-sectional design does not allow for considering temporality in judging whether a causal
relation exists; rather, it provides evidence of an association with no clear cause–effect identification.
Thus, reverse-causation should be taken into account; namely, we are not able to determine whether
the inflammatory potential of the diet affects sleep quality or sleep features lead to unhealthy dietary
habits. Second, the structured assessment methods that were used to assess dietary habits, such as the
FFQ, are known to be associated with recall bias [58,59]. However, no ideal method to collect dietary
data exists and the FFQ is widely used in nutritional epidemiology.
5. Conclusions
In conclusion, these findings confirm our original hypothesis that the inflammatory potential
of the diet is associated with sleep quality in adults. Future studies with prospective designs with
the potential to provide stronger data for causal inference should be designed and implemented.
Interventions to improve diet quality might consider including a dietary component that aims to lower
chronic systemic inflammation to prevent cognitive decline and improve sleep quality.
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